Am J Transplant, Volume 16, Suppl 3 Archives - Page 23 of 180 - ATC Abstracts

2016 American Transplant Congress
Risk Factors for Hospitalization Among Waitlisted End Stage Renal Disease Patients.
K. Newman,^1,2 A. Adams,² S. Pastan,² R. Lynch,² R. Zhang,¹ R. Patzer.^1,2
¹Emory University Rollins School of Public Health, Atlanta, GA; ²Emory University School of Medicine, Atlanta, GA.
Background: For End Stage Renal Disease Patients (ESRD) waitlisted for a deceased donor kidney, hospitalization is associated with lower likelihood of transplantation and worse outcomes.…
2016 American Transplant Congress
Alkaline Phosphatase a New Marker for Graft Outcome and High Pulse Wave Velocity in Renal Transplant Recipients.
S. Sezer,¹ E. Tutal,¹ Z. Bal,¹ B. Demirci,¹ M. Haberal.²
¹Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey; ²General Surgery, Baskent University Faculty of Medicine, Ankara, Turkey.
Purpose: Alkaline phosphatase (ALP) is a marker of bone turnover which is widely used for estimating type of bone turnover in patients with end-stage renal…
2016 American Transplant Congress
Trends in Liver Transplant Rates and Waitlist Survival.
M. Bowring, A. Massie, X. Luo, L. Kucirka, E. Chow, A. Cameron, D. Segev.
JHU, Baltimore.
Long term changes in access to deceased-donor liver transplantation(DDLT) due to persistent growth of the waitlist, stagnant organ availability, and intermittent allocation policy changes have…
2016 American Transplant Congress
The Role of Obesity in Survival Outcomes of Liver Transplant Recipients with High MELD Score.
S.-H. Chang,¹ N. Carlsson,¹ X. Liu,² J. Wellen,³ J. Hagopian,⁴ T. Horwedel,⁴ T. Alhamad.⁵
¹Division of Public Health Sciences, Department of Surgery, Washington University in St. Louis, St. Louis; ²Division of Biostatistics, Washington University in St. Louis, St. Louis; ³Department of Surgery, Washington University in St. Louis, St. Louis; ⁴Department of Pharmacy, Barnes Jewish Hospital, St. Louis; ⁵Renal Division, Washington University, St. Louis.
Background:Obesity has become an epidemic in the United States. More than one third of adults are obese, defined as having body mass index (BMI) greater…
2016 American Transplant Congress
Systematic Review and Meta-Analysis of the Impact of Computed Tomography Assessed Skeletal Muscle Mass on Outcome in Patients Awaiting or Undergoing Liver Transplantation.
J. van Vugt,¹ S. Levolger,¹ R. de Bruin,¹ J. van Rosmalen,² H. Metselaar,³ J. IJzermans.¹
¹Surgery, Erasmus University Medical Center, Rotterdam, Netherlands; ²Biostatistics, Erasmus University Medical Center, Rotterdam, Netherlands; ³Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, Netherlands.
BackgroundAlthough liver transplant outcome has improved significantly, the shortage of human organs remains prevalent. Therefore, strict patient selection is of paramount importance. Recently, low CT-assessed…
2016 American Transplant Congress
Human Leukocyte Antigen (HLA) Mismatch Impact on Lung transplants outcomes.
G. Chery,¹ L. Snyder,¹ M. Durheim,¹ S. Palmer,¹ M. Neely.²
¹Medicine, Duke University School of Medicine, Durham, NC; ²Biostatistics & Bioinformatics, Duke University School of Medicine, Durham, NC.
PurposeReports on the impact of HLA mismatching on survival and its role in the development of bronchiolitis obliterans syndrome (BOS) or chronic allograft lung dysfunction…
2016 American Transplant Congress
Clinical Significance of C3d Binding Donor Specific Anti-HLA Antibodies (DSA) Detected by Single Antigen Beads (SAB) After Kidney Transplantation.
R. Pelletier,¹ I. Balazs,² P. Adams,³ P. Steller,³ N. DiPaola,⁴ L. Rankin,³ A. Diez,⁵ M. Henry.¹
¹Surgery/Transplant, The Ohio State University Wexner Medical Center, Columbus, OH; ²Discovery Research, Immucor, Inc, Stamford, CT; ³Tissue Typing Laboratory, The Ohio State University Wexner Medical Center, Columbus, OH; ⁴Methodist Hospital, Houston, TX; ⁵Nephrology, The Ohio State University Wexner Medical Center, Columbus, OH.
A new Luminex-based SAB method detects DSA compliment fixing via C3d-binding. This study compares the clinical outcomes in kidney recipients that developed de novo DSA…
2016 American Transplant Congress
Antibody-Mediated Rejection Can Be Assessed by Histology When DSA Is Unknown or Negative.
J. Reeve,¹ P. Halloran.²
¹Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada; ²Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Diagnosis of antibody-mediated rejection (ABMR) in kidney transplants currently requires the presence of donor-specific antibody (DSA) and histologic lesions above somewhat arbitrary cutoffs. DSA is…
2016 American Transplant Congress
Evaluation of Dose Dependent Rabbit Anti-Thymocyte Globulin Induction in Risk-Stratified Kidney Transplant Recipients.
I. Gutman, M. Misel, D. McKay, A. Hemming, J. Kerr, K. Mekeel.
UC San Diego Health System, San Diego, CA.
Background: Rabbit anti-thymocyte globulin (rATG) is a depleting polyclonal antibody often used for induction following kidney transplantation to help prevent acute rejection. The optimal dosage…
2016 American Transplant Congress
Induction Therapy in Low Risk African American Kidney Transplant Recipients: Donor Factors.
F. Al Ammary,¹ S. Bae,¹ A. Massie,¹ N. Dagher,¹ E. King,¹ A. Wiseman,² D. Segev.¹
¹JHU, Baltimore; ²CU, Denver.
African Americans (AA) are at a higher risk of acute rejection and graft loss compared to non-AA kidney transplant (KT) recipients. Guidelines specify induction choices…